X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (154796) 154796
Publication (10002) 10002
Book Review (1164) 1164
Newsletter (966) 966
Book Chapter (708) 708
Magazine Article (470) 470
Conference Proceeding (292) 292
Dissertation (231) 231
Newspaper Article (142) 142
Book / eBook (127) 127
Reference (82) 82
Trade Publication Article (54) 54
Web Resource (40) 40
Data Set (14) 14
Government Document (9) 9
Streaming Video (6) 6
Journal / eJournal (3) 3
Paper (3) 3
Transcript (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (75306) 75306
animals (68300) 68300
male (64994) 64994
female (40833) 40833
rats (33400) 33400
index medicus (25725) 25725
middle aged (21634) 21634
adult (21069) 21069
adrenergic beta-antagonists - therapeutic use (20679) 20679
pharmacology & pharmacy (17665) 17665
aged (15561) 15561
adrenergic beta-antagonists - pharmacology (13781) 13781
in vitro techniques (12020) 12020
cardiac & cardiovascular systems (11263) 11263
dose-response relationship, drug (10948) 10948
isoproterenol - pharmacology (10309) 10309
blood pressure - drug effects (10272) 10272
neurosciences (10052) 10052
heart rate - drug effects (9478) 9478
adrenergic beta-agonists - pharmacology (9447) 9447
mice (9280) 9280
adrenergic alpha-antagonists - pharmacology (8998) 8998
time factors (8896) 8896
propranolol - pharmacology (7740) 7740
adrenergic alpha-agonists - pharmacology (7647) 7647
treatment outcome (7612) 7612
norepinephrine - pharmacology (7427) 7427
rats, sprague-dawley (7400) 7400
biochemistry & molecular biology (7364) 7364
physiology (6874) 6874
dogs (6492) 6492
receptors, adrenergic, beta - metabolism (6475) 6475
hypertension - drug therapy (6412) 6412
rats, wistar (6161) 6161
rats, inbred strains (6151) 6151
receptors, adrenergic, beta - drug effects (5715) 5715
drug therapy, combination (5535) 5535
adolescent (5497) 5497
receptors, adrenergic, beta - physiology (5277) 5277
hypertension (5255) 5255
rabbits (5130) 5130
double-blind method (5066) 5066
norepinephrine (4984) 4984
adrenergic beta-antagonists - administration & dosage (4894) 4894
kinetics (4870) 4870
adrenergic beta-agonists - therapeutic use (4714) 4714
medicine, general & internal (4644) 4644
cells, cultured (4637) 4637
myocardium - metabolism (4620) 4620
receptors, adrenergic, alpha - drug effects (4593) 4593
risk factors (4593) 4593
receptors (4518) 4518
beta-adrenergic receptor (4517) 4517
heart failure (4501) 4501
peripheral vascular disease (4494) 4494
hemodynamics - drug effects (4492) 4492
research (4479) 4479
asthma - drug therapy (4474) 4474
electric stimulation (4418) 4418
norepinephrine - metabolism (4292) 4292
receptors, adrenergic, alpha - physiology (4280) 4280
drug therapy (4263) 4263
guinea pigs (4256) 4256
cell biology (4137) 4137
adrenergic beta-antagonists - adverse effects (4052) 4052
child (4041) 4041
clonidine - pharmacology (4026) 4026
phenylephrine - pharmacology (3964) 3964
angiotensin-converting enzyme inhibitors - therapeutic use (3963) 3963
heart failure - drug therapy (3941) 3941
adrenergic receptors (3931) 3931
analysis (3926) 3926
signal transduction (3877) 3877
cyclic amp - metabolism (3804) 3804
rat (3784) 3784
blood pressure (3780) 3780
muscle contraction - drug effects (3778) 3778
epinephrine - pharmacology (3744) 3744
receptors, adrenergic - drug effects (3723) 3723
heart - drug effects (3712) 3712
mortality (3689) 3689
adrenergic beta blockers (3682) 3682
adrenergic alpha-antagonists - therapeutic use (3647) 3647
aged, 80 and over (3578) 3578
expression (3566) 3566
phosphorylation (3535) 3535
care and treatment (3526) 3526
drug interactions (3487) 3487
heart (3473) 3473
activation (3438) 3438
respiratory system (3393) 3393
electrocardiography (3361) 3361
propanolamines - pharmacology (3360) 3360
physiological aspects (3340) 3340
propranolol (3333) 3333
prazosin - pharmacology (3330) 3330
article (3281) 3281
asthma (3278) 3278
endocrinology & metabolism (3257) 3257
research article (3251) 3251
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (123) 123
Online Resources - Online (32) 32
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UTL at Downsview - May be requested (2) 2
University Archives - Archives (2) 2
Gerstein Science - Theses (1) 1
Providence Healthcare - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (142162) 142162
German (3060) 3060
Russian (2863) 2863
French (2348) 2348
Japanese (1838) 1838
Italian (901) 901
Spanish (898) 898
Chinese (811) 811
Polish (542) 542
Portuguese (233) 233
Dutch (220) 220
Danish (181) 181
Czech (171) 171
Swedish (157) 157
Norwegian (151) 151
Hungarian (149) 149
Korean (117) 117
Romanian (113) 113
Slovak (84) 84
Finnish (75) 75
Ukrainian (63) 63
Bulgarian (61) 61
Hebrew (47) 47
Serbian (38) 38
Turkish (38) 38
Croatian (32) 32
Lithuanian (14) 14
Persian (12) 12
Bosnian (4) 4
Afrikaans (3) 3
Catalan (3) 3
Slovenian (3) 3
Arabic (2) 2
Greek (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Europace, ISSN 1099-5129, 07/2017, Volume 19, Issue 7, pp. 1211 - 1219
Postural tachycardia syndrome (POTS), a common and debilitating cardiovascular disorder, is characterized by an exaggerated heart rate increase during... 
Autoimmunity | Adrenergic receptors | Postural tachycardia syndrome | Allosteric activation | Vasovagal syncope | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | SYNCOPE | INAPPROPRIATE SINUS TACHYCARDIA | ORTHOSTATIC INTOLERANCE | NITROGLYCERIN | HYPOTENSION | CONSENSUS STATEMENT | Receptors, Adrenergic, alpha-1 - metabolism | Cricetulus | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Male | Receptors, Adrenergic, beta-2 - immunology | Receptors, Adrenergic, beta-2 - drug effects | Adrenergic beta-1 Receptor Agonists - pharmacology | Case-Control Studies | Adrenergic alpha-1 Receptor Agonists - pharmacology | Adrenergic beta-2 Receptor Agonists - pharmacology | Receptors, Adrenergic, alpha-1 - immunology | Dose-Response Relationship, Drug | Young Adult | Transfection | Receptors, Adrenergic, beta-1 - immunology | Adult | Female | Receptors, Adrenergic, beta-1 - drug effects | CHO Cells | Postural Orthostatic Tachycardia Syndrome - immunology | Receptors, Adrenergic, alpha-1 - drug effects | Receptors, Adrenergic, beta-2 - genetics | Rats | Receptors, Adrenergic, beta-1 - metabolism | Abdominal Muscles - blood supply | Arterioles - drug effects | Vasoconstriction - drug effects | Postural Orthostatic Tachycardia Syndrome - blood | Receptors, Adrenergic, beta-2 - metabolism | Animals | Arterioles - metabolism | Postural Orthostatic Tachycardia Syndrome - diagnosis | Receptors, Adrenergic, alpha-1 - genetics | Adolescent | Receptors, Adrenergic, beta-1 - genetics | In Vitro Techniques | Clinical Research | Editor's Choice | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Immunologi inom det medicinska området | Immunology in the medical area
Journal Article
2000, Taylor & Francis series in pharmaceutical sciences, ISBN 0748408045, 189
Introduction - Structure and Function of the ß3-Adrenoreceptor, A.D. Strosberg and C.C. Gerhardt Regulation of the ß3-Adrenoreceptor Signalling Efficacy, M.... 
Adrenergic beta agonists | Beta adrenoceptors
eBook
1997, Lung biology in health and disease, ISBN 9780824794965, Volume 106., xvi, 443
Book
Journal of Chemical Information and Modeling, ISSN 1549-9596, 05/2015, Volume 55, Issue 5, pp. 1045 - 1061
Journal Article
NATURE, ISSN 0028-0836, 01/2011, Volume 469, Issue 7329, pp. 241 - 244
beta-adrenergic receptors (beta ARs) are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins upon binding catecholamine agonist ligands... 
CRYSTALLIZATION | AMINO-ACID | ACTIVATION | LIGAND-BINDING | BETA-ADRENERGIC-RECEPTORS | PROTEIN-COUPLED RECEPTOR | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | CRYSTALLOGRAPHY | HIGH-AFFINITY BINDING | BETA-ADRENERGIC RECEPTOR | Dobutamine - metabolism | Hydroxyquinolines - chemistry | Catecholamines - metabolism | Albuterol - pharmacology | Amphetamines - pharmacology | Adrenergic beta-1 Receptor Antagonists - pharmacology | Crystallography, X-Ray | Adrenergic beta-1 Receptor Agonists - chemistry | Structure-Activity Relationship | Receptors, Adrenergic, beta-1 - chemistry | Adrenergic beta-1 Receptor Agonists - pharmacology | Turkeys | Adrenergic beta-1 Receptor Antagonists - chemistry | Drug Design | Adrenergic beta-1 Receptor Antagonists - metabolism | Dobutamine - chemistry | Isoproterenol - chemistry | Binding Sites | Hydroxyquinolines - pharmacology | Amphetamines - chemistry | Drug Partial Agonism | Albuterol - metabolism | Hydroxyquinolines - metabolism | Isoproterenol - metabolism | Models, Molecular | Receptors, Adrenergic, beta-1 - metabolism | Serine - chemistry | Serine - metabolism | Dobutamine - pharmacology | Animals | Hydrogen Bonding | Amphetamines - metabolism | Isoproterenol - pharmacology | Protein Stability - drug effects | Albuterol - chemistry | Ligands | Protein Conformation | Adrenergic beta-1 Receptor Agonists - metabolism
Journal Article
Circulation Research, ISSN 0009-7330, 03/2017, Volume 120, Issue 7, pp. 1103 - 1115
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 07/2013, Volume 346, Issue 1, pp. 138 - 145
Melatonin is currently considered a promising drug for glaucoma treatment because of its ocular hypotensive and neuroprotective effects. We have investigated... 
OPEN-ANGLE GLAUCOMA | MESSENGER-RNA | TRABECULAR MESHWORK | FIXED COMBINATION | BROWN ADIPOCYTES | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | INTRAOCULAR-PRESSURE | ADJUNCTIVE THERAPY | CILIARY EPITHELIAL-CELLS | PHARMACOLOGICAL-PROPERTIES | Neuroprotective Agents - therapeutic use | Receptors, Adrenergic, alpha-2 - genetics | Ophthalmic Solutions - pharmacology | Epithelial Cells - metabolism | Intraocular Pressure - drug effects | Adrenergic alpha-2 Receptor Agonists - chemistry | Receptors, Adrenergic, alpha-2 - metabolism | Adrenergic Agonists - pharmacology | Adrenergic Agonists - therapeutic use | Male | Ocular Hypotension - chemically induced | Receptors, Adrenergic, alpha-2 - chemistry | Adrenergic alpha-2 Receptor Agonists - pharmacology | Ciliary Body - metabolism | Receptors, Adrenergic, beta-2 - chemistry | Adrenergic beta-Antagonists - pharmacology | Adrenergic alpha-2 Receptor Agonists - therapeutic use | Neuroprotective Agents - pharmacology | Tryptamines - pharmacology | Neuroprotective Agents - adverse effects | Tryptamines - therapeutic use | Glaucoma - physiopathology | Adrenergic beta-Antagonists - therapeutic use | Tryptamines - adverse effects | Nerve Tissue Proteins - antagonists & inhibitors | Rabbits | Ciliary Body - cytology | Receptors, Adrenergic, beta-2 - genetics | Nerve Tissue Proteins - agonists | Cells, Cultured | Glaucoma - drug therapy | Nerve Tissue Proteins - genetics | Receptors, Adrenergic, beta-2 - metabolism | Drug Synergism | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Melatonin - adverse effects | Melatonin - analogs & derivatives | Adrenergic Agonists - adverse effects | Animals | Adrenergic beta-Antagonists - chemistry | Ciliary Body - drug effects | Melatonin - therapeutic use | Melatonin - pharmacology
Journal Article
NATURE, ISSN 0028-0836, 01/2011, Volume 469, Issue 7329, pp. 175 - 180
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2009, Volume 54, Issue 19, pp. 1747 - 1762
Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers countermeasures aimed to restore cardiac output. These... 
adrenergic receptor | beta-blockers | heart failure | sympathomimetic inotropes | sympatholytics | sympathetic nervous system | CARDIAC-INSUFFICIENCY BISOPROLOL | OBSTRUCTIVE SLEEP-APNEA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | AUTONOMIC FUNCTION | RANDOMIZED CONTROLLED-TRIAL | DILATED CARDIOMYOPATHY | LEFT-VENTRICULAR DYSFUNCTION | BETA-BLOCKADE | POSITIVE AIRWAY PRESSURE | BETA-ADRENERGIC RECEPTOR | Receptors, Adrenergic, alpha-1 - metabolism | Sympathetic Nervous System - drug effects | Humans | Heart Failure - physiopathology | Adrenergic alpha-Antagonists - therapeutic use | Receptors, Adrenergic, beta-2 - drug effects | Sympathetic Nervous System - physiopathology | Sympatholytics - therapeutic use | Cardiotonic Agents - therapeutic use | Receptors, Adrenergic - genetics | Parasympathetic Nervous System - physiopathology | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Sympathomimetics - therapeutic use | Receptors, Adrenergic, alpha-1 - drug effects | Heart Failure - genetics | Heart Failure - metabolism | Receptors, Adrenergic, beta-2 - metabolism | Heart Failure - drug therapy | Polymorphism, Genetic | Randomized Controlled Trials as Topic | Parasympathetic Nervous System - drug effects | Exercise Tolerance | Renin-Angiotensin System - drug effects | Hemodynamics - drug effects | Proteins | Confidence intervals | Heart rate | Heart failure | Heart attacks | Rodents | Mortality | Hospitalization | Kinases | Beta blockers
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2017, Volume 114, Issue 7, pp. 1708 - 1713
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 10/2016, Volume 122, pp. 601 - 610
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 06/2013, Volume 169, Issue 3, pp. 528 - 538
Background and Purpose PDE3 and/or PDE4 control ventricular effects of catecholamines in several species but their relative effects in failing human ventricle... 
inotropism and lusitropism | human heart failure | phosphodiesterases 3 and 4 | noradrenaline and adrenaline | metoprolol | β1 and β2 adrenoceptors | and β | adrenoceptors | Adrenergic beta-1 Receptor Antagonists - adverse effects | Heart Failure - surgery | Cyclic Nucleotide Phosphodiesterases, Type 3 - chemistry | Norepinephrine - pharmacology | Adrenergic alpha-Agonists - chemistry | Phosphodiesterase 3 Inhibitors - pharmacology | Humans | Middle Aged | Adrenergic beta-1 Receptor Antagonists - pharmacology | Heart Failure - physiopathology | Myocardial Contraction - drug effects | Receptors, Adrenergic, beta-1 - chemistry | Adrenergic beta-1 Receptor Antagonists - therapeutic use | Adrenergic beta-Agonists - chemistry | Epinephrine - agonists | Receptors, Adrenergic, beta-2 - chemistry | Cardiotonic Agents - therapeutic use | Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Cyclic Nucleotide Phosphodiesterases, Type 4 - chemistry | Adrenergic beta-2 Receptor Antagonists - pharmacology | Adrenergic beta-Agonists - pharmacology | Heart Transplantation | Metoprolol - therapeutic use | Receptors, Adrenergic, beta-1 - metabolism | Drug Resistance - drug effects | Heart Failure - metabolism | Anti-Arrhythmia Agents - therapeutic use | Cardiotonic Agents - pharmacology | Metoprolol - adverse effects | Norepinephrine - agonists | Phosphodiesterase 4 Inhibitors - pharmacology | Receptors, Adrenergic, beta-2 - metabolism | Heart Failure - drug therapy | Heart Ventricles - physiopathology | Anti-Arrhythmia Agents - adverse effects | Adrenergic alpha-Agonists - pharmacology | Heart Ventricles - metabolism | In Vitro Techniques | Epinephrine - pharmacology | Heart Ventricles - drug effects | Research Paper with
Journal Article
Circulation Research, ISSN 0009-7330, 02/2013, Volume 112, Issue 3, pp. 476 - 486
RATIONALE:Short-term β-adrenergic stimulation promotes contractility in response to stress but is ultimately detrimental in the failing heart because of... 
heart failure | cardiac progenitor cells | adrenergic regulation | adrenergic receptors | adult stem cells | PROTEIN-KINASE-A | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | DILATED CARDIOMYOPATHY | LEFT-VENTRICULAR DYSFUNCTION | FAILING HEART | GENE-EXPRESSION | MEDIATED DNA-SYNTHESIS | PERIPHERAL VASCULAR DISEASE | CYCLE PROGRESSION | BETA-ADRENERGIC RECEPTORS | HEMATOLOGY | Cyclin D1 - metabolism | Phosphorylation | Coculture Techniques | Humans | Male | G-Protein-Coupled Receptor Kinase 2 - metabolism | Receptors, Adrenergic, beta-2 - drug effects | Proto-Oncogene Proteins c-kit - metabolism | Stem Cells - metabolism | Adrenergic beta-2 Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Stem Cell Transplantation | Transfection | RNA Interference | Time Factors | Myocardial Infarction - pathology | Cell Death | Receptors, Adrenergic, beta-1 - drug effects | Nitric Oxide Synthase Type III - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Adrenergic beta-2 Receptor Antagonists - pharmacology | Disease Models, Animal | Myocardial Infarction - surgery | Cell Survival | Receptors, Adrenergic, beta-2 - genetics | Cells, Cultured | Receptors, Adrenergic, beta-1 - metabolism | Myocardial Infarction - metabolism | Receptors, Adrenergic, beta-2 - metabolism | Myocytes, Cardiac - pathology | Myocytes, Cardiac - transplantation | Animals | Myocytes, Cardiac - drug effects | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Myocytes, Cardiac - metabolism | Stem Cells - drug effects | Stem Cells - pathology | Receptors, Adrenergic, beta-1 - genetics | Cell Proliferation - drug effects | Mice | Mitogen-Activated Protein Kinase 1 - metabolism
Journal Article
Neuroscience, ISSN 0306-4522, 2010, Volume 170, Issue 4, pp. 1098 - 1109
Abstract Endogenous cannabinoid receptors are widely distributed throughout the CNS, including the brainstem, and modulate a variety of functions, including... 
Neurology | endocannabinoid | neonate | catecholamine | respiratory rhythm generator | in vitro | Neonate | Endocannabinoid | Catecholamine | In vitro | Respiratory rhythm generator | SPINAL-CORD PREPARATION | IMMUNOHISTOCHEMICAL LOCALIZATION | CANNABINOID RECEPTOR EXPRESSION | NEUROSCIENCES | CB1 RECEPTOR | IN-VITRO | RAT FRONTAL-CORTEX | PRE-BOTZINGER COMPLEX | BRAIN | MODULATION | ANESTHETIZED RATS | Animals, Newborn | Arachidonic Acids - physiology | Cannabinoid Receptor Modulators - pharmacology | Medulla Oblongata - drug effects | Periodicity | Adrenergic alpha-2 Receptor Antagonists - pharmacology | Arachidonic Acids - pharmacology | Yohimbine - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Cannabinoid Receptor Modulators - physiology | Animals | Respiratory Center - drug effects | Adrenergic alpha-1 Receptor Antagonists - pharmacology | Prazosin - pharmacology | Polyunsaturated Alkamides - pharmacology | Mice | In Vitro Techniques | Receptors, Adrenergic, alpha-2 - physiology | Medulla Oblongata - physiology | Endocannabinoids | Receptors, Adrenergic, alpha-1 - physiology | Respiratory Center - physiology | Immunohistochemistry | Tyrosine | Infants (Newborn) | Prazosin | Neurosciences | Yohimbine | Depression, Mental | Noradrenaline | Adrenergic receptors | Receptors, Adrenergic, alpha-1 | Biochemistry, Molecular Biology | Receptors, Adrenergic, alpha-2 | Respiratory Center | Polyunsaturated Alkamides | Life Sciences | Arachidonic Acids | Receptor, Cannabinoid, CB1 | Medulla Oblongata | Biomolecules | Adrenergic alpha-1 Receptor Antagonists | Adrenergic alpha-2 Receptor Antagonists
Journal Article